Lyrus Life Sciences

  • Lyrus Receives US FDA approval for Critical UTI treatment in the US
About Lyrus Life Sciences

Lyrus Life Sciences, is a fast growing global provider of drug development solutions for prescription and over-the-counter pharmaceutical products for regulated markets. Lyrus is headquartered in Bengaluru, India and was incorporated in 2016, by Mr C P Bothra, one among India’s foremost leader in the pharmaceutical industry, with more than 40 years of industry experience, with a specific objective of providing value added products across therapies. The leadership team at Lyrus is focused and brings more than 300 years of combined experience wit...

  • IN
  • 2019
    On CPHI since
  • 4
  • 250 - 499
Company types
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Primary activities
Pharmaceutical Company (generic finished products)
Contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from Lyrus Life Sciences (4)

  • Methenamine Hippurate Tabs 1000 mg

    Product Methenamine Hippurate Tabs 1000 mg

    METHENAMINE is used to prevent urinary tract infections due to bacteria. It is not used to treat an active infection. It will not work for colds, flu, or other viral infections.
  • Metformin PR tablets

    Product Metformin PR tablets

    Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems.
  • Nitrofurantoin Capsules

    Product Nitrofurantoin Capsules

    Nitrofurantoin is used to treat urinary tract infections. This medicine is an antibiotic. It works by killing bacteria or preventing their growth.
  • Sucralfate tablets

    Product Sucralfate tablets

    sucralfate, sold under various brand names, is a medication used to treat stomach ulcers, gastroesophageal reflux disease, radiation proctitis, and stomach inflammation and to prevent stress ulcers. Its usefulness in people infected by H. pylori is limited.

Lyrus Life Sciences Resources (2)

  • News Lyrus Receives US FDA approval for Critical UTI treatment in the US

    Lyrus has received US FDA approval for our Abbreviated New Drug Application (ANDA) for 'Methenamine Hippurate Tablets USP, 1 gram', an AB-rated, substitutable generic version of Hiprex®. 
  • Brochure Lyrus Life Science Brochure

    Introduction:The Lyrus Life Science brochure provides a comprehensive overview of our company's capabilities, management profile, research and development strengths, and production facilities. It serves as a valuable resource to gain insights into our operations and the therapies we specialize in. At Lyrus Life Science, we are committed to developing innovative products using non-infringing technologies, revolutionizing the healthcare industry.